BofA lowered the firm’s price target on Illumina (ILMN) to $90 from $110 and keeps an Underperform rating on the shares. Shares have fallen 25% ...

The top-up is expected to help Singapore compete in areas including AI and quantum computing. Read more at straitstimes.com.

Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.

Shares of Illumina Inc. ILMN shed 1.51% to $100.24 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to 6,114.63 and Dow ...

Carl Icahn’s Icahn Capital disclosed in an SEC filing its holdings as of December 31, 2024. The fund increased its stakes in two holdings, ...

Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...

China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

Illumina, Inc. (NASDAQ:ILMN – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Wednesday after Morgan Stanley lowered their price target on the stock from $150.00 to ...

Two U.S. firms, namely PVH Corp. and Illumina, Inc., were added to China's unreliable entity list on Feb. 4. The move could subject the companies to one or multiple measures under Article 10 of the ...